RS

Ram Sanjeevaiah Greeshma

Active Director Director DIN 11283887
DIN 11283887 First appointment Sep 2025 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Ram Sanjeevaiah Greeshma

Data last updated:

Ram Sanjeevaiah Greeshma is a Director at Cosmeraki Pharmaceuticals Private Limited (since 2025). The company operates in Pharma.

DIN 11283887
Primary Designation Director
Industry Pharma
First Appointment 06 Sep 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director06 Sep 20252025Active

Board colleagues of Ram Sanjeevaiah Greeshma

Directorship timeline

Open interactive timeline →
Cosmeraki Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Ram Sanjeevaiah Greeshma

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ram Sanjeevaiah Greeshma

Ram Sanjeevaiah Greeshma currently holds 1 directorship: Cosmeraki Pharmaceuticals Private Limited (Director, since 06 Sep 2025).

Ram Sanjeevaiah Greeshma was first appointed on 06 Sep 2025 as Director at Cosmeraki Pharmaceuticals Private Limited.

The current boards of Ram Sanjeevaiah Greeshma's companies include Sakaleshpur Pandu Jyothi (Cosmeraki Pharmaceuticals Private Limited), Umadevi Gangadhar Bagodi (Cosmeraki Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available